SEC 13F Intelligence

Islet Management, LP / IMMU

Islet Management, LP’s Immunomedics Inc Position

Does Islet Management, LP own Immunomedics Inc (IMMU)? Not currently — the last reported position was 300.0K shares worth $11M in Q2 2020; the fund’s latest 13F (Q3 2023) no longer reports it.

Position Value
$11M
Q2 2020
Shares
300.0K
% of Portfolio
+1.21%
Quarters Held
1
position exited

Position History IMMU

Reported value by quarter
Q2 ’20: $11MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2020300.0K$11M+1.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Islet Management, LP’s full portfolio or all institutional holders of IMMU.